Mark Sheptoff Financial Planning, LLC Gsk PLC Transaction History

Mark Sheptoff Financial Planning, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $16,063 - $18,248	-382 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$38.88 - $45.31 $3,188 - $3,715	82 Added 27.33%	382 $17,000
Q1 2021 May 11, 2021	SELL	$34.27 - $40.01 $20,562 - $24,006	-600 Reduced 66.67%	300 $11,000
Q3 2020 Nov 12, 2020	BUY	$38.11 - $42.99 $7,622 - $8,598	200 Added 28.57%	900 $34,000
Q2 2020 Aug 10, 2020	BUY	$37.87 - $43.58 $7,573 - $8,716	200 Added 40.0%	700 $29,000
Q3 2019 Nov 12, 2019	SELL	$40.46 - $43.52 $28,322 - $30,464	-700 Reduced 58.33%	500 $21,000
Q1 2019 May 10, 2019	SELL	$38.57 - $42.69 $7,714 - $8,538	-200 Reduced 14.29%	1,200 $50,000
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $35,775 - $38,421	900 Added 180.0%	1,400 $56,000
Q1 2018 May 08, 2018	BUY	$36.18 - $40.15 $14,472 - $16,060	400 Added 400.0%	500 $20,000
Q4 2017 Feb 09, 2018	SELL	$35.34 - $41.9 $164,331 - $194,835	-4,650 Reduced 97.89%	100 $4,000
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $187,340 - $197,362	4,750	4,750 $193,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $82.8B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.